Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protocadherin gamma-C4 (PCDHGC4) is a calcium-dependent neural cell adhesion molecule belonging to the cadherin superfamily, encoded by the PCDHGC4 gene in the gamma cluster on chromosome 5[1][2][4]. The protocadherin gamma cluster consists of 22 genes subdivided into three subfamilies (A, B, C), and PCDHGC4 is one of three genes in the more distantly related subfamily C[1][2]. Structurally, it is a type I transmembrane protein with six extracellular cadherin (EC) domains and a variable cytoplasmic region, followed by a constant cytoplasmic C-terminal region encoded by shared exons within the cluster[1][4]. PCDHGC4 is essential for establishment and maintenance of specific neuronal connections, and plays a unique, non-redundant role in postnatal neuronal survival, particularly for cortical inhibitory interneurons (cINs) during developmental programmed cell death[2][3]. Genetic disruption of PCDHGC4 in model organisms leads to severe neurodevelopmental phenotypes and early postnatal lethality, illustrating its indispensability[2][3][4]. In humans, loss-of-function mutations are highly constrained and associated with neurodevelopmental disease, suggesting an essential conserved function without redundancy among gamma cluster members[2][3][4][1]. No specific drugs, biomarkers, or safety concerns are associated for therapeutic targeting as of current research[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protocadherin gamma-C4 (PCDHGC4).